Correlation Between Zai Lab and Enzon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Zai Lab and Enzon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zai Lab and Enzon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zai Lab and Enzon Pharmaceuticals, you can compare the effects of market volatilities on Zai Lab and Enzon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zai Lab with a short position of Enzon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zai Lab and Enzon Pharmaceuticals.
Diversification Opportunities for Zai Lab and Enzon Pharmaceuticals
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Zai and Enzon is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Zai Lab and Enzon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzon Pharmaceuticals and Zai Lab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zai Lab are associated (or correlated) with Enzon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzon Pharmaceuticals has no effect on the direction of Zai Lab i.e., Zai Lab and Enzon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Zai Lab and Enzon Pharmaceuticals
Given the investment horizon of 90 days Zai Lab is expected to generate 0.61 times more return on investment than Enzon Pharmaceuticals. However, Zai Lab is 1.65 times less risky than Enzon Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Enzon Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 3,962 in Zai Lab on September 1, 2024 and sell it today you would lose (1,077) from holding Zai Lab or give up 27.18% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 25.05% |
Values | Daily Returns |
Zai Lab vs. Enzon Pharmaceuticals
Performance |
Timeline |
Zai Lab |
Enzon Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zai Lab and Enzon Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zai Lab and Enzon Pharmaceuticals
The main advantage of trading using opposite Zai Lab and Enzon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zai Lab position performs unexpectedly, Enzon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzon Pharmaceuticals will offset losses from the drop in Enzon Pharmaceuticals' long position.Zai Lab vs. C4 Therapeutics | Zai Lab vs. Erasca Inc | Zai Lab vs. Cullinan Oncology LLC | Zai Lab vs. Legend Biotech Corp |
Enzon Pharmaceuticals vs. Pmv Pharmaceuticals | Enzon Pharmaceuticals vs. NewAmsterdam Pharma | Enzon Pharmaceuticals vs. Tempest Therapeutics | Enzon Pharmaceuticals vs. IO Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |